Abstract
Epstein–Barr virus (EBV)-associated polymorphic lymphoid proliferations resembling polymorphic post-transplant lymphoproliferative disorders are a rare but recognised complication of the human immunodeficiency virus (HIV). These account for fewer than 5 % of HIV-associated lymphomas, and little information has been published regarding their treatment and outcome. Of the reported cases, many have presented with extranodal disease, not typical of lymphoma. We report the case of a patient presenting with lung infiltrates shown to be the result of an EBV-associated polymorphic lymphoproliferation resembling a polymorphic post-transplant lymphoproliferative disorder. The patient was simultaneously found to be HIV positive and commenced on highly active antiretroviral therapy. Without any specific anti-neoplastic treatment, the patient recovered completely and within 20 months had no symptoms or radiological evidence of a lymphoproliferative disorder. This illustrates the importance of recognising this uncommon condition in HIV-positive patients and avoiding potentially unnecessary chemotherapy.
References
Nador RG, Chadburn A, Gundappa G et al (2003) Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol 27(3):293–302
Raphael M, Said J, Borisch B et al (2008) Immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon, pp 335–352
Grogg KL, Miller RF, Dogan A (2007) HIV infection and lymphoma. J Clin Pathol 60:1365–1372
Tao J, Valderrama E (1999) Epstein–Barr virus-associated polymorphic B-cell lymphoproliferative disorder in the lungs of children with AIDS: a report of two cases. Am J Surg Pathol 23(5):560–566
Fujita H, Nishikori M, Takaori-Kondo A et al (2010) A case of HIV-associated lymphoproliferative disease that was successfully treated with highly active antiretroviral therapy. Int J Hematol 91:692–698
Kingma DW, Mueller BU, Frekko K et al (1999) Low-grade monoclonal Epstein–Barr virus associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a child with acquired immunodeficiency syndrome. Arch Pathol Lab Med 123:83–87
Wang X, Nathan S, Catchatourian R, Richter H III, Kovarik P (2007) Polymorphic lymphoid proliferation presenting as ileocecal intussusception. Ann Hematol 86:453–454
Martin SI, Zukerberg L, Robbins G (2005) Reactive Epstein–Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS. Clin Infect Dis 41:e76–e79
Gucalp A, Noy A (2009) Spectrum of HIV lymphoma. Curr Opin Hematol 17:362–367
Hoffmann C, Wolf E, Fatkenheuer G et al (2003) Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. AIDS 17:1521–1529
Oppenheim S (2009) Prognosis in HIV-associated malignancies #214. J Palliat Med 12(9):835–836
Monini P, Sgadari C, Toschi E et al (2004) Antitumour effects of antiretroviral therapy. Cancer 4:861–875
Conflicts of interest
The authors declare that they have no conflict of interest.
Funding sources
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buxton, J., Leen, C. & Goodlad, J.R. Polymorphic lymphoid proliferations occurring in HIV-positive patients: report of a case responding to HAART. Virchows Arch 461, 93–98 (2012). https://doi.org/10.1007/s00428-012-1261-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-012-1261-8